Recent Posts
- FDA Okays Blood Test for Ovarian Cancer
- Replication At DNA Damage Sites Highlights Fanconi Anemia And Breast Cancer Proteins
- ASCO To Hold Annual Meeting In Chicago For The Next Ten Years: City Seen As Best Choice To Host Meeting That Continues To Grow
- Protein Partnership Leads To Pediatric Tumor Regression
- ASCO Awarded CEO Cancer Gold Standard: Achievement Underscores Organization’s Commitment To The Health And Well-Being Of Its Employees
Random Posts
- Analysis Questions Breast and Prostate Cancer Screening
- New Phase II Study Showed Trastuzumab-DM1 Shrank Tumors In Women With Highly Advanced HER2-Positive Breast Cancer
- Public Want Ban On Sunbeds For Under 18s, UK
- Stanford, Palo Alto Medical Foundation Launch Comprehensive Breast Cancer Study
- Cancer Survivors: Exercise Guidelines Are Coming
- The Need For Cardio-Oncology: Treating Cancer And Protecting The Heart
- Enzyme Necessary For Development Of Healthy Immune System
- American Cancer Society To Recognize Corporate Employers Changing The Course Of The Cancer Fight
- ASCO: Investigational Drug Active in Advanced Kidney Cancer
- Novartis Gains Rights To Two Oral Targeted Investigational Therapies Focusing On Patients With Life-threatening Blood Disorders And Cancers
Prescription Cancer Drugs
Thyroid Cancer Increase More Than Screening (CME/CE)
Posted by: admin in Prescription Cancer Drugs on August 12th, 2009
LITTLE FALLS, N.J., July 13 — The increasing incidence of thyroid cancer in the U.S. is more than the result of better screening, researchers said.
- Explain that incidence rates of thyroid cancer increased among tumors of all sizes — not just the smallest ones, which would be expected if the increase was attributable to increased screening alone.
- Note that the researchers call for the investigation of other potential explanations, including diet, environmental influences, and molecular pathways.
Incidence rates rose for tumors of all sizes — not just the smallest ones, as it would if more cases were simply being caught by increased screening, Amy Y. Chen, MD, MPH, and colleagues reported online in Cancer.
“Our finding that even the largest tumors and tumors with distant spread of disease had an increasing incidence suggests that other reasons for this increase, including environmental, dietary, and genetic causes, need to be explored,” the researchers said.
Previous studies have found an increasing incidence of thyroid cancer, and some researchers have pointed to increased detection through more widespread and aggressive use of ultrasound and image-guided biopsy.
But increasing incidence rates can also reflect a true increase in the number of cancers, the researchers said.
So, to determine potential causes of the increase, researchers looked at data on 30,766 thyroid cancer patients from the Surveillance, Epidemiology, and End Results (SEER) study. All were diagnosed between 1988 and 2005.
Mortality rates were unchanged over that period, despite higher rates of diagnosis, the researchers said.
Among women, incidence of thyroid cancer increased from 6.4 per 100,000 to 14.9 per 100,000, while incidence among men increased from 2.5 per 100,000 to 5.1 per 100,000.
Although the highest rate of increase was for tumors under 1 cm (P<0.001), there were significant increases in all tumor sizes, particularly those greater than 4 cm, they noted.
| The researchers reported no conflicts of interest. |
Primary source: Cancer
Source reference:
Chen AY, et al “Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005″ Cancer 2009; DOI: 10.1002/cncr.24416.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.
| Copyright 2009 |online pharmacy ambien no prescription buy xanax online no prescription online tramadol buying xanax online buy soma





